Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia Clinical research trials and Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia. Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia clinical trial. Test subjects typically receive the most effective healthcare possible for their Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "D" Clinical Trials Conditions > Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia

Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia



Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia

For Condition: Schizophrenia
Status: Recruiting
Sponsor(s): Abbott Laboratories ,
Synopsis: The purpose of this study is to assess the 14-day and 12-week safety and efficacy of Depakote ER used in combination with either olanzapine or risperidone versus antipsychotic monotherapy with olanzapine or risperidone for the treatment of schizophrenia.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: KEY INCLUSION CRITERIA - Acute exacerbation of schizophrenia as defined by: subject recently hospitalized or is in the process of being admitted to a hospital or an acute care inpatient psychiatric treatment facility; and has a PANNS Total score of 70 or greater at the time of screening and at randomization based on a 1-7 point scale; and has a score on any two of the four items from psychoisis cluster of the BPRS (extracted from the PANSS) that correspond to the positive symptoms (hallucinatory behavior, unusual thought content, sonceptual disorganization and suspiciousness) totaling 8 or greater; and has a total of 6 or greater on one of the following two pairs of items from the BPRS (extracted from the PANSS): hostility and uncooperativeness or excitememtn and tension. - Current DSM-IV-TR diagnosis of schizophrenia as confirmed by the SCID - Positive response to antipsychotics in the previous 2 years KEY EXCLUSION CRITERIA - Current diagnosis of schizoaffective disorder, drug-induced psychosis, manic episode or major depressive episode. - At the time of screening, has been hospitalized for more than 14 days for the current episode - Has ever taken clozapine - Has had more than 3 psychiatric hospitalizations in the previous 6 months or has had more than 8 weeks of psychiatric hospitalization in the previous 12 months - Has serious violent, homicidal, suicidal ideation - Has received depot medictions fluphenazine decanoate and/or haloperidon decanoate within 2 or 4 weeks prior to randomization respectively - Urine toxicology screen is positive for phencyclidine (PCP), opiates, cocaine or amphetamines - History of alcohol or substance dependence within the past month - Has taken any valproate product for a psychiatric indication within the previous 30 days - Has received an investigational drug within the last 30 days
Total Enrollment: 

Location and Contact Information:


Additional Information:
Study ID Numbers:
  M02-547; 
Study Start Date: 
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00073164

Other Schizophrenia Studies:
1. The Efficacy and Safety of Risperidone in the Treatment of Adolescents with Schizophrenia

2. Genetic Aspects of Neurologic and Psychiatric Disorders

3. A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits

4. Treatment of Childhood Onset Psychiatric Disorders with Intravenous Immunoglobulin (IVIg)

5. Treatment Response to Rehabilitation in Patients with Schizophrenia

Related Studies:

Other Schizophrenia Clinical Trials
Other Maryland Clinical Trials
Other Rockville Clinical Trials

Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia

Modify your Search

  Other Schizophrenia Clinical Trials
  Other Maryland Clinical Trials
  Other Rockville Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103